Additional Biopsies After CRC Biopsy Not Tied to Metachronous CRC
Biopsy of nontumor sites after initial colorectal cancer biopsy was not linked to a risk for metachronous cancer.
Biopsy of nontumor sites after initial colorectal cancer biopsy was not linked to a risk for metachronous cancer.
The prevalence of screening for colorectal cancer remained stable.
Eating unprocessed red meat is associated with an increased risk of colorectal cancer in Black women.
There were no significant differences in most efficacy outcomes between 2 treatment sequences.
A new study in untreated metastatic colorectal cancer met its progression-free survival endpoint for intermittent treatment with FOLFIRI and panitumumab.
Patients with RAS wild-type metastatic colorectal cancer had an improvement in overall survival when modified FOLFOX6 was combined with panitumumab vs bevacizumab.
Researchers developed and assessed logistic prediction models for the detection of advanced neoplasia and colorectal cancer.
Adding nab-paclitaxel to gemcitabine did not appear to improve survival in a real-world cohort.
New research supports starting colorectal cancer screening before 50 years of age in women.
Patients with certain cancers have an increased risk of cancer-specific mortality that persists for 30 to 35 years after diagnosis.